Sarepta Therapeutics, Inc., headquartered in Cambridge, MA, appears in the available FY2024-FY2026 LCA dataset with 25 filing records, a limited sponsorship-filing pattern among U.S. employers tracked here. Sarepta Therapeutics, Inc. is also matched with 4 PERM filings in the available FY2024-FY2025 PERM dataset, a descriptive filing pattern rather than an individual green-card outcome. These are public LCA filings, not visa approvals, hires, or open roles, and the figures generally exclude equity, bonus, and benefits.
No elevated signal appears in the currently matched LCA and USCIS datasets. This is descriptive filing history, not immigration, legal, or employment advice.
Sarepta Therapeutics, Inc. has 25 H-1B LCA filing records in FY2024-FY2026.
The available filings do not provide enough complete wage observations for a peer comparison.
4 PERM filings are matched to this employer; this is not a green-card success rate.
Sarepta Therapeutics, Inc. shows limited H-1B LCA filing activity in the available FY2024-FY2026 dataset, with 25 public LCA records. The largest filed role clusters include Principal Statistical Programmer. Major worksite filing activity appears in Cambridge, MA, Andover, MA, and Burlington, MA. These records are not final visa approvals, hires, or open roles.
The available LCA records do not provide enough complete wage observations for a median filed wage signal on this employer page.
Sarepta Therapeutics, Inc. has 4 matched PERM filings in the available FY2024-FY2025 dataset. The PERM-to-H-1B Filing Ratio is 16%, meaning PERM filings divided by H-1B LCA filings in the available public datasets; it is descriptive filing activity, not an individual green-card success rate.
Annual LCA filings across the available fiscal years.
Distribution is not available for this page because the source filings do not include enough complete salary observations.